Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Kosan and NCI to clinically develop geldanamycin analogues

Nov. 20, 2002

ENMD-0995 trial for patients with multiple myeloma under way

Nov. 19, 2002

GC-C technology has potential as marker and target for gastric and esophageal cancers

Nov. 19, 2002

Helsinn grants CJ Corp. license and distribution rights for palonosetron in Korea

Nov. 19, 2002

New antiproliferative compounds isolated from fungal species

Nov. 19, 2002

Grant awarded for first clinical trial of squalamine in the treatment of prostate cancer

Nov. 18, 2002

Cell Therapeutics earns milestone payment

Nov. 18, 2002

ChromaVision and NewBiotics to collaborate on cancer therapeutic development

Nov. 18, 2002

Phase II trial of TNFerade initiated in patients with esophageal cancer

Nov. 18, 2002

Chemoprotective agent heads for clinical trials at ProMetic

Nov. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...